Search
Heyuan Biotech Receives IPO Approval on STAR Market from Listing Committee Meeting
2 day ago /
Read about 0 minute
Author：小编
On July 1st, Heyuan Biotech's initial public offering (IPO) application secured approval from the Listing Review Committee of the Shanghai Stock Exchange, marking it as the pioneering company to clear the review following the revival of the fifth set of listing criteria on the STAR Market. Heyuan Biotech, a pioneering enterprise dedicated to innovative drug research and development, has successfully concluded Phase III clinical trials for its core product.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
